Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups

Author： >  

Publisher： Adis International

ISSN： 1178-1661

Source： The Patient: Patient-Centered Outcomes Research, Vol.2, Iss.2, 2009-06, pp. : 89-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

By Lanas Angel   Scheiman James  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 163-173

Informa Healthcare

Access to resources Recommend Favorite

Rationale for a Primary Prevention Study Using Low‐Dose Aspirin To Prevent Coronary and Cerebrovascular Disease in the Elderly

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 5, 1991-05 ,pp. : 484-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using prophylactic proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid: A Quantitative Study in Patients with Cardiovascular Risk

By Moberg Christina  

The Patient: Patient-Centered Outcomes Research, Vol. 4, Iss. 2, 2011-06 ,pp. : 103-113

Adis International

Access to resources Recommend Favorite

The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 365-374

John Wiley & Sons Inc

Access to resources Recommend Favorite